Justin Loke
9PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jun 10, 2025
An in vivo barcoded CRISPR-Cas9 screen identifies Ncoa4-mediated ferritinophagy as a dependence in Tet2-deficient hematopoiesis.Justin Loke, Peter G Kim, Thuy T P Nguyen
|Sep 12, 2024
Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy.Jad Othman, Angela Hwang, Maximillian Brodermann
|Jun 12, 2023
Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes.Justin Loke, Vinit Upasani, Charlotte Gaskell
|Apr 14, 2023
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS.Justin Loke, Nicholas McCarthy, Aimee Jackson
|May 25, 2022
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.Justin Loke, Myriam Labopin, Charles Craddock
|Sep 07, 2021
Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy.Justin Loke, Marlen Metzner, Rebecca Boucher
Pageof 2
Frequent Collaborators
3 joint publications
Charles Craddock
2 joint publications
Richard Dillon
2 joint publications
Sylvie Freeman
2 joint publications
Rui Zhao
2 joint publications
Anjum Khan
1 joint publications
Georgia Andrew
1 joint publications
Maria Gilleece
1 joint publications
Paresh Vyas
1 joint publications
Anne Parker
1 joint publications
Jiri Pavlu
